Redir

Thursday, December 23, 2010

Martek Biosciences Option Buyers Accused by SEC of Inside Trades

Unknown buyers of Martek Biosciences Corp. options were sued by the U.S. Securities and Exchange Commission over claims they traded on inside information of Royal DSM NV"s acquisition of the company....
Read More...
[Source: BusinessWeek.com -- Top News]

No comments:

Post a Comment